Outpatient ocular brachytherapy: The USC Experience

• DOI: 10.1016/j.adro.2021.100737
• Publication Date: 2021-06-11T06:39:43Z
• Authors: Sarah Joh; Mary E. Kim; Michael Reilly; Sue Y. Zhou; Jonathan Kim; Richard L. Jennelle; Jesse L. Berry
• Keywords: Medical record

Ocular brachytherapy is a standard-of-care surgical procedure for globe salvage in the treatment of uveal melanoma. The involves placement and subsequent removal radioactive plaque several days later. At many locations, patients are admitted on an inpatient basis until due to radiation safety concerns. However, may be discharged home after insertion, subsequently return medical facility removal. This study aimed evaluate systematic financial benefit outpatient ocular program at "?>the University Southern California (USC) Roski Eye Institute 30 years.A single-institution retrospective record review was performed all 275 who underwent tumors between January 1, 1989 December 31, 2019 assess occurrences reportable and/or events. protocols our institution described. Data hospital-adjusted expenses per day from American Hospital Association's 2018 Annual Survey were used as proxy costs health care system perform cost-benefit analysis comparing versus brachytherapy.Of procedures over 30-year period that reviewed, there no internally or externally patient There adverse events related transportation hospital, not returning removal, operative issues removing time cancelled delayed cases, loss material. Additionally, estimates reduced USC's by average $24,722 treated with brachytherapy.With appropriate measures, allows safely added decreased burden both broader system.